Pfizer Begins Trials In Children Under 12 With Low-Dose COVID-19 Vaccine


Pfizer is moving forward with trials in children under 12-years-old with low dose Covid-19 vaccine.

Photo credit *Getty Images*


Sponsored Content

Sponsored Content